Purvi Shah

Purvi Shah

Auto-generated profile, based on publicly available information

Purvi Shah

Parul Institute of Pharmacy and Research, Parul University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Food and Drug Analysis
Verified
Journal Article
Open access
KPKalpana G. Patel
Kalpana G. Patel
PSPratik M. Shah
Pratik M. Shah
PSPurvi A. Shah
Purvi A. Shah
TGTejal R. Gandhi
Tejal R. Gandhi
A high-performance thin-layer chromatographic method for simultaneous determination of nadifloxacin, mometasone furoate, and miconazole nitrate was developed and validated as per International Conference on Harmonization guidelines. High-performance thin-layer chromatographic separation was performed on aluminum plates precoated with silica gel 60F254 and methanol:ethyl acetate:toluene: acetonitrile:3M ammonium formate in water (1:2.5:6.0:0.3:0.2, % v/v) as optimized mobile phase at detection wavelength of 224 nm. The retardation factor (Rf) values for nadifloxacin, mometasone furoate, and miconazole nitrate were 0.23, 0.70, and 0.59, respectively. Percent recoveries in terms of accuracy for the marketed formulation were found to be 98.35-99.76%, 99.36-99.65%, and 99.16-100.25% for nadifloxacin, mometasone furoate, and miconazole nitrate, respectively. The pooled percent relative standard deviation for repeatability and intermediate precision studies was found to be < 2% for three target analytes. The effect of four independent variables, methanol content in total mobile phase, wavelength, chamber saturation time, and solvent front, was evaluated by fractional factorial design for robustness testing. Amongst all four factors, volume of methanol in mobile phase appeared to have a possibly significant effect on retention factor of miconazole nitrate compared with the other two drugs nadifloxacin and mometasone furoate, and therefore it was important to be carefully controlled. In summary, a novel, simple, accurate, reproducible, and robust high-performance thin-layer chromatographic method was developed, which would be of use in quality control of these cream formulations.

1 January 2009 in Dissolution Technologies
Verified
Journal Article
Closed access
VTV. T. Thakkar
V. T. Thakkar
PSP. A. Shah
P. A. Shah
TST. G. Soni
T. G. Soni
MPM. Y. Parmar
M. Y. Parmar
MGM. C. Gohel
M. C. Gohel
TGT. R. Gandhi
T. R. Gandhi

27 November 2018 in Journal of Taibah University for Science
Verified
Journal Article
Open access
PSPurvi Shah
Purvi Shah
TPTosha Pandya
Tosha Pandya
MGMukesh Gohel
Mukesh Gohel
Vaishali ThakkarVaishali Thakkar
Vaishali Thakkar
A accurate, precise and robust isocratic HPLC method has been developed and validated for simultaneous determination of Rifampicin and Ofloxacin. The chromatographic separation was carried out on Kinetex C18, 100 A Phenomenex column with a mixture of 0.03M Potassium dihydrogen phosphate buffer pH 3.0: Acetonitrile (55:45) as mobile phase at 230 nm. The retention times were 2.91 and 4.87 min for Ofloxacin and Rifampicin, respectively. Calibration plots were linear over the concentration range 1–5 and 2–10 µg/ml for Rifampicin and Ofloxacin, respectively. The method was validated for linearity, sensitivity accuracy, precision, and robustness. Percent recoveries were found to be close to 100% with low variability. Fractional factorial design with four factors was chosen for robustness testing. The volume of acetonitrile and flow rate showed significant effect on retention factor of both the drugs and asymmetry factor of ofloxacin. The method may be adopted for routine analysis at industry.

1 January 2017 in Journal of Taibah University for Science
Verified
Journal Article
Open access
PSPurvi Shah
Purvi Shah
JPJalpa Patel
Jalpa Patel
KPKalpana Patel
Kalpana Patel
TGTejal Gandhi
Tejal Gandhi
The present study examines simultaneous multiple response optimization using Derringer's desirability function for the development of an HPTLC method to detect Clonazepam and Paroxetine hydrochloride in pharmaceutical dosage form. Central composite design (CCD) was used to optimize the chromatographic conditions for HPTLC. The independent variables used for the optimization were the n-butanol content in the mobile phase, the chamber saturation time and the distance travelled. HPTLC separation was performed on aluminium plates pre-coated with silica gel 60 F254 as the stationary phase using n-butanol:glacial acetic acid:water (9:2:0.5% v/v/v) as the mobile phase. Quantification was achieved based on a densitometric analysis of Clonazepam and Paroxetine hydrochloride over the concentration range of 40–240ng/band and 300–1800ng/band, respectively, at 288nm. The method yielded compact and well-resolved bands at Rf of 0.77±0.02 and 0.34±0.02 for Clonazepam and Paroxetine hydrochloride, respectively. The linear regression analysis for the calibration plots produced r2=0.9958 and r2=0.9989 for Clonazepam and Paroxetine hydrochloride, respectively. The precision, accuracy, robustness, specificity, limit of detection and limit of quantitation of the method were validated according to the ICH guidelines. The factors evaluated in the robustness test were determined to have an insignificant effect on the selected responses. The results indicate that the method is suitable for the routine quality control testing of marketed tablet formulations

1 September 2015 in Acta Chromatographica
Verified
Journal Article
Closed access
RMR. P. Mangukiya
R. P. Mangukiya
RPR. A. Patel
R. A. Patel
PSP. A. Shah
P. A. Shah
KPK. G. Patel
K. G. Patel

1 August 2018 in JPC – Journal of Planar Chromatography – Modern TLC
Verified
Journal Article
Closed access
KGKaruna Gohel
Karuna Gohel
KPKalpana Patel
Kalpana Patel
PSPurvi Shah
Purvi Shah
LHLal Hingorani
Lal Hingorani
TGTejal Gandhi
Tejal Gandhi
A simple, specific, and quantitative high-performance thin-layer chromatography (HPTLC) method has been developed for the simultaneous determination of quercetin, kaempferol, and keto- beta-boswellic acid in the herbal extracts of Spinacia oleracea and Boswellia serrata. Chromatographic development was performed using n-hexane. ethyl acetate. glacial acetic acid (6.4:3.6:0.2, % v/v) as optimized mobile phase on TLC aluminum plate precoated with silica gel 60 F-254 and optimized resolution between quercetin and kaempferol (R-12) and between kaempferol and KBBA (R-23) were 2.11 and 2, respectively. The detection of quercetin, kaempferol, and keto-beta-boswellic acid was carried out at 272 nm. Box-Behnken design was applied for optimization of the chromatographic conditions and combination of factors such as the volume of n-hexane (A), solvent front (B), and chamber saturation time (C) which were likely to affect R-F, and resolution of quercetin, kaempferol, and keto-beta-boswellic acid were identified from preliminary trials and further optimized using response surface design. The drugs were satisfactorily resolved with R-F values of 0.22 +/- 0.02, 0.40 +/- 0.02, and 0.54 +/- 0.02 for quercetin, kaempferol, and keto-beta-boswellic acid, respectively. The linear ranges were found to be 1500-3500, 200-600, and 1040-3120 ng band(-1) for quercetin, kaempferol, and keto-beta-boswellic acid. The accuracy and precision measured were less than 2% relative standard deviation for all markers. The sensitivity of the method in terms of limit of detection (LOD) and limit of quantitation (LOQ) were measured. Among three factors, the significant factor found was the volume of hexane that resulted in a change in the R-F of all three markers. The proposed method was found to be accurate, precise, reproducible, robust, and specific and can be applicable for the simultaneous determination of quercetin, kaempferol, and keto-beta-boswellic acid for the quality control testing of extracts and medicinal plants.